Interferon does not improve outcomes for hospitalized adults with COVID-19, clinical trial finds — ScienceDaily
A clinical trial has found that treatment with the immunomodulator interferon beta-1a plus the antiviral remdesivir was not superior to treatment with remdesivir alone in hospitalized adults with COVID-19 pneumonia.…
